Navigation Links
Webinar: Blood-Based Proteomic Classifier for the Molecular Characterization of Pulmonary Nodules, a Case Study in the Discovery and Validation of a Molecular Diagnostic
Date:11/27/2013

Toronto, Canada (PRWEB) November 27, 2013

The results of a major study were published recently in Science Translational Medicine (STM), which suggest that quantifying a combination of blood proteins can distinguish between benign lung nodules and early-stage lung cancer with high probability.

In this webinar, Daniel Chelsky, Chief Scientific Officer at Caprion Proteomics, will discuss candidate identification, assay development, testing and results, beginning with the derivation of the initial list of candidates, to the identification of the five blood-based proteins, which together constitute the biomarker panel used in the commercial protein expression test, developed in collaboration with Integrated Diagnostics (InDi).

Specific topics covered by the speaker will include the use of Multiple Reaction Monitoring (MRM or SRM) technology as a critical factor in the successful development of a multi-protein classifier panel, as well as the various strategies used to ensure disease specificity and relevance in the final panel.

For more information on this webinar or to register, visit http://xtalks.com/Molecular-Characterization-of-Pulmonary-Nodules.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.

Contact:
Michelle Tran (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/11/prweb11375932.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Protiviti Webinar: Mapping Your Strategic Course - IPO or M&A?
2. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
3. Blood-Based Circulating Microvesicles (cMV) Data to be Presented at the 2013 International Society for Extracellular Vesicles (ISEV)
4. Adaptive Biotechnologies launches clonoSEQ, a more sensitive, accurate assay to detect minimal residual disease (MRD) in blood-based cancers.
5. Waters Teams With Biochemical Society on Proteomics Training Day and Symposium
6. Elsevier Launches New Open Access Journal: Translational Proteomics
7. Director of Proteomics at the Broad Institute of MIT and Harvard, Steven Carr, to Deliver Pittcon 2014 Wallace H. Coulter Plenary Lecture
8. Research and Markets: Proteomics - Technologies, Markets and Companies - 2013 Report
9. Life Technologies to Accelerate Development of Ion Torrent Semiconductor Technology for Proteomic Applications in Research, Applied and Clinical Markets
10. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
11. Molecular Diagnostics - Global Strategic Business Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or ... China, today announced its financial results for the fourth quarter ... 2016 Financial Highlights Total sales in ... terms, or increased by 13.6% in USD terms to $77.6 ... Gross profit increased by 13.3% to $46.8 ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... Discovery Services portfolio to include an array of biochemical analyses critical for ... data to drive their hit-to-lead and SAR programs, including inhibitor potency and selectivity, ...
(Date:2/23/2017)... 2017  Imanis Life Sciences announced today the ... vaccinia viruses for virotherapy research. These viruses are ... proprietary, vaccinia virus-based technology platform for research use. ... a partnership with Genelux to offer researchers, for ... use in research," said Dr. Kah Whye ...
(Date:2/23/2017)... ... , ... The Greater Gift Initiative, Inc , (GGI) a Winston-Salem, NC ... GGI's mission is to advance global health and highlight the greater good of clinical ... each clinical trial volunteer. The vision of GGI is to serve as a philanthropic ...
Breaking Biology Technology:
(Date:1/26/2017)... 26, 2017  Acuity Market Intelligence today released ... Digital Identity".  Acuity characterizes 2017 as a "breakout" ... adoption reflects a new understanding of the potential ... and digital identity are often perceived as threats ... , Principal of Acuity Market intelligence. "However, taken ...
(Date:1/24/2017)... 2017  It sounds simple and harmless—an electronic ... vital signs and alerts parents on their smart ... level drops. But pediatric experts argue that such ... no evidence of medical benefits, especially to healthy ... to parents of healthy babies, promising peace of ...
(Date:1/19/2017)... India , January 19, 2017 According to a ... Opportunities and Forecast, 2014 - 2022," the global biometric sensor market is expected ... 2016 to 2022. In 2015, Asia-Pacific dominated the global ... and private sectors. Continue Reading ... ...
Breaking Biology News(10 mins):